Portfolio news 0

Tissue Regenix Group plc

Tissue Regenix Group (AIM:TRX), the regenerative medical devices company, provides a trading update for the year ended 31 December 2020.

Centessa Pharmaceuticals plc

ApcinteX presents results from the single ascending dose study of SerpinPC in healthy volunteers and persons with severe haemophilia (Part 1 of AP-0101) at EAHAD2021

First Light Fusion Ltd

Professor Jerry Chittenden joins First Light Fusion’s Advisory Board

Microbiotica Ltd

Microbiotica expands management team with appointments of Chief Medical Officer and Chief Operating Officer

Inivata Limited

Inivata Raises $35 million in Second Close of Series C Financing

AGM customer Infinity Wax launches second graphene-enhanced product

Mirriad Advertising Ltd

Appointment of Chief Technology Officer

Diurnal Ltd

Chronocort® Phase 3 and Safety Extension Study results published in JCEM

Oxford Nanopore Technologies Plc

Mobile laboratories use LamPORE COVID-19 test, UK Government LamPORE evaluation report shows high accuracy

Close of Accelerated Bookbuild and PrimaryBid Offer